DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 164 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,369 | -9.5% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $3,723 | -11.2% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $4,194 | -5.3% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $4,431 | +14.3% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $3,876 | +31.7% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,943 | -7.8% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $3,192 | +6.4% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $4,000 | -33.3% | 300 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $6,000 | +100.0% | 300 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $3,000 | +200.0% | 300 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -66.7% | 300 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $3,000 | +200.0% | 300 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
Maven Securities LTD | 264,989 | $931,000 | 0.29% |
Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |